<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AD494FBD-A2F9-4A44-855E-10E179D87561"><gtr:id>AD494FBD-A2F9-4A44-855E-10E179D87561</gtr:id><gtr:name>Anaxsys Technology Limited</gtr:name><gtr:address><gtr:line1>MED IC4 SCIENCE PARK , KEELE</gtr:line1><gtr:city>NEWCASTLE</gtr:city><gtr:postCode>ST5 5NL</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AD494FBD-A2F9-4A44-855E-10E179D87561" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>AD494FBD-A2F9-4A44-855E-10E179D87561</gtr:id><gtr:name>Anaxsys Technology Limited</gtr:name><gtr:address><gtr:line1>MED IC4 SCIENCE PARK , KEELE</gtr:line1><gtr:city>NEWCASTLE</gtr:city><gtr:postCode>ST5 5NL</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>228093.0</gtr:offerGrant><gtr:projectCost>506873.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/57837FA5-E72A-4052-8FA4-F7AE2DA87DC7"><gtr:id>57837FA5-E72A-4052-8FA4-F7AE2DA87DC7</gtr:id><gtr:firstName>Zia</gtr:firstName><gtr:surname>Mursaleen</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=720741"><gtr:id>4BE9B3A0-E1DB-497E-A3AD-38DDCC0ED580</gtr:id><gtr:title>Anaxsys Technology Ltd Asthma Monitoring Device Pilot Study</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>GRD Development of Prototype</gtr:grantCategory><gtr:grantReference>720741</gtr:grantReference><gtr:abstractText>Asthma attacks are caused by poor control of symptoms. Control is achieved by effective
monitoring. Current asthma monitoring method is low technology, difficult to interpret and
uncomfortable to use causing low compliance to monitoring regimes.
Worldwide approximately 300 million people have asthma and approximately 30 million
people in Europe are currently living with this condition. The annual cost of Asthma in
Europe is estimated to be EUR17.7bn, including direct cost of care, emergency admissions
and cost to the economy of working days lost. Productivity lost to asthma is estimated at
EUR9.8billion per year.
However, the cost to life, quality of life and the economic burden could be substantially
improved; severe asthma attacks are due to poor control of the condition. Indeed the drug
therapies are safe and effective and management plans for asthma would achieve sufficient
control to prevent asthma attacks if correctly followed. However, the peak flow meter, the
standard equipment for home monitoring to achieve that control, has various limitations.
Many asthma sufferers find the forced expiration technique required to use peak flow meters
difficult and can even cause bronchospasm resulting in poor patient compliance. Childhood
asthma is also increasing and is under diagnosed; WHO estimates by 25%-40%. Children
under 8 cannot use peak flow meters because they are unable to achieve the forced expiration
technique.
Anaxsys Technology Ltd (Anaxsys) is a medical device company formed in 2002. Anaxsys
has developed and patented core sensor technology which is enabling us to develop and
market a range of novel respiratory devices that challenge existing solutions and deliver
improved patient outcomes. Our overall aim is to develop and commercialise an innovative
asthma monitoring device, Breathe EasyFlow, which uses normal tidal breathing and shape of
the breath profile to give an indicator of current asthma status.</gtr:abstractText><gtr:fund><gtr:end>2017-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2016-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>228093</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">720741</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>